COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES

secukinumab
$3965.6400per ML

Strength

150 mg/mL

NDC

00078063998

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

1/7/2026

Active Ingredients

SECUKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125504

On Market Since

1/21/2015

Pharmacological Classes

Interleukin-17A Antagonist
Interleukin-17A Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.9%

1Y

+6.9%

3Y

N/A

5Y

N/A

All

+10.8%